Mainz Biomed, Liquid Biosciences make discovery of mRNA biomarkers
Mainz Biomed (MYNZ) announced it has entered into a License and Option Agreement with Liquid Biosciences to access a portfolio of novel mRNA ...
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic Cancer in Blood ...
On COVID-19 anniversary, concerns about the lessons unlearned
Public health experts say the United States learned some things from COVID-19, but gaps remain in the public health ...
News Medical on MSN21h
BIOVECTRA is honored with 2025 CDMO Leadership Award for biologics
BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 ...